Nefropatía falciforme. Manifestaciones clínicas y nuevos mecanismos implicados en el daño renal

Thein, 2018, treat the older adult with sickle cell disease, Blood, 132, 1750, 10.1182/blood-2018-03-818161 Ropero Gradilla, 2017, Hemoglobinopatías talasemias, 309 Piel, 2017, Sickle Cell Disease, N Engl J Med, 376, 1561, 10.1056/NEJMra1510865 Piel, 2010, Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis, Nat Commun, 1, 104, 10.1038/ncomms1104 Piel, 2013, Global burden of sickle cell anaemia in children under five, 2010-2050: Modelling based on demographics, excess mortality, and interventions, PLoS Med, 10, e1001484, 10.1371/journal.pmed.1001484 Bardón Cancho, 2020, Actualización del registro español de hemoglobinopatías de niños y adultos, Med Clin (Barc), S0025-7753, 30717 Standards for Clinical Care of Adults with Sickle Cell Disease in the UK-2018 [consultado 20 Jul 2020] Disponible en: https://www.sicklecellsociety.org/resource/sicklecellstandards/ Cela, 2019, Guía de Práctica Clínica de la Enfermedad de Células Falciformes En: Sociedad Española de Hematología y Oncología Pediátricas (SEHOP), Ediciones CeGe Salinas Cisneros, 2020, Recent Advances in the Treatment of Sickle Cell Disease, Front Physiol, 11, 435, 10.3389/fphys.2020.00435 Estepp, 2017, A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy, Am J Hematol, 92, 1333, 10.1002/ajh.24906 Nevitt, 2017, Hydroxyurea (hydroxycarbamide) for sickle cell disease, Cochrane Database Syst Rev, 4, CD002202 Sharpe, 2014, treat renal complications in sickle cell disease, Blood, 123, 3720, 10.1182/blood-2014-02-557439 Nath, 2015, Sickle cell disease: Renal manifestations and mechanisms, Nat Rev Nephrol, 11, 161, 10.1038/nrneph.2015.8 Naik, 2017, The spectrum of sickle hemoglobin-related nephropathy: From sickle cell disease to sickle trait, Expert Rev Hematol, 10, 1087, 10.1080/17474086.2017.1395279 López Revuelta, 2011, Afectación renal en la enfermedad falciforme, Nefrologia, 31, 591 Alvarez, 2012, Effect of hydroxyurea treatment on renal function parameters: Results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia, Pediatr Blood Cancer, 59, 668, 10.1002/pbc.24100 Naik, 2018, Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review, Ann Intern Med, 169, 619, 10.7326/M18-1161 Moudgil, 1996, Protracted gross hematuria in sickle cell trait: Response to multiple doses of 1-desamino-8-D-arginine vasopressin, Pediatr Nephrol, 10, 210, 10.1007/BF00862083 Gabrovsky, 2010, Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease, Pediatr Blood Cancer, 54, 148, 10.1002/pbc.22295 Herard, 1998, Massive gross hematuria in a sickle cell trait patient with renal papillary necrosis. Conservative approach using a balloon ureteral catheter to tamponade the papilla bleeding, Eur Urol, 34, 161, 10.1159/000019703 Haymann, 2010, Glomerular hyperfiltration in adult sickle cell anemia: A frequent hemolysis associated feature, Clin J Am Soc Nephrol, 5, 756, 10.2215/CJN.08511109 Nath, 2001, Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease, Am J Pathol, 158, 893, 10.1016/S0002-9440(10)64037-0 Vazquez, 2014, Hyperfiltration is associated with the development of microalbuminuria in patients with sickle cell anemia, Am J Hematol, 89, 1156, 10.1002/ajh.23817 Kriz, 2005, Pathways to nephron loss starting from glomerular diseases-insights from animal models, Kidney Int, 67, 404, 10.1111/j.1523-1755.2005.67097.x Maigne, 2010, Medicine (Baltimore)., 89, 18, 10.1097/MD.0b013e3181ca59b6 Ataga, 2014, The glomerulopathy of sickle cell disease, Am J Hematol, 89, 907, 10.1002/ajh.23762 Bakir, 1987, Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study, Am J Nephrol, 7, 110, 10.1159/000167444 Gosmanova, 2014, Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease, J Investig Med, 62, 804, 10.1097/01.JIM.0000446836.75352.72 Liem, 2019, American Society of Hematology 2019 guidelines for sickle cell disease: Cardiopulmonary and kidney disease, Blood Adv, 3, 3867, 10.1182/bloodadvances.2019000916 Guasch, 2006, Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure, J Am Soc Nephrol, 17, 2228, 10.1681/ASN.2002010084 Gordeuk, 2008, Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency, Am J Hematol, 83, 15, 10.1002/ajh.21016 Audard, 2010, Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension, Nephrol Dial Transplant, 25, 2524, 10.1093/ndt/gfq083 Sklar, 1990, Acute renal failure in sickle cell anemia, Int J Artif Organs, 13, 347, 10.1177/039139889001300604 Aderibigbe, 1994, Glomerular function in sickle cell disease patients during crisis, Afr J Med Med Sci., 23, 153 McPherson Yee, 2011, Chronic kidney disease and albuminuria in children with sickle cell disease, Clin J Am Soc Nephrol, 6, 2628, 10.2215/CJN.01600211 Platt, 1994, Mortality in sickle cell disease Life expectancy and risk factors for early death, N Engl J Med, 330, 1639, 10.1056/NEJM199406093302303 Serjeant, 2009, The changing face of homozygous sickle cell disease: 102 patients over 60 years, Int J Lab Hematol, 31, 585, 10.1111/j.1751-553X.2008.01089.x Abbott, 2002, Sickle cell nephropathy at end-stage renal disease in the United States: Patient characteristics and survival, Clin Nephrol, 58, 9, 10.5414/CNP58009 Huang, 2013, Improved survival among sickle cell kidney transplant recipients in the recent era, Nephrol Dial Transplant, 28, 1039, 10.1093/ndt/gfs585 Asnani, 2013, Determining glomerular filtration rate in homozygous sickle cell disease: Utility of serum creatinine based estimating equations, PLoS One, 8, e69922, 10.1371/journal.pone.0069922 Asnani, 2015, Cystatin C: A useful marker of glomerulopathy in sickle cell disease?, Blood Cells Mol Dis, 54, 65, 10.1016/j.bcmd.2014.07.018 Belisário, 2019, Sickle cell disease nephropathy: An update on risk factors and potential biomarkers in pediatric patients, Biomark Med, 13, 967, 10.2217/bmm-2019-0105 Kato, 2007, Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes, Blood Rev, 21, 37, 10.1016/j.blre.2006.07.001 Gupta, 1991, Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait, J Clin Invest, 88, 1963, 10.1172/JCI115521 Guasch, 1999, Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans, J Am Soc Nephrol, 10, 1014, 10.1681/ASN.V1051014 Statius van Eps, 1970, Nature of concentrating defect in sickle-cell nephropathy: Microradioangiographic studies, Lancet, 1, 450, 10.1016/S0140-6736(70)90836-6 Greco, 2017, Imaging of Renal Medullary Carcinoma, J Kidney Cancer VHL, 4, 1 Moreno, 2012, AKI associated with macroscopic glomerular hematuria: Clinical and pathophysiologic consequences, Clin J Am Soc Nephrol, 7, 175, 10.2215/CJN.01970211 Buehler, 2010, Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design, Trends Mol Med, 16, 447, 10.1016/j.molmed.2010.07.006 Belcher, 2014, Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, 123, 377, 10.1182/blood-2013-04-495887 Villagra, 2007, Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin, Blood, 110, 2166, 10.1182/blood-2006-12-061697 Chintagari, 2015, Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease, Blood Cells Mol Dis, 54, 302, 10.1016/j.bcmd.2014.12.001 Ofori-Acquah, 2020, Hemopexin deficiency promotes acute kidney injury in sickle cell disease, Blood, 135, 1044 Rubio-Navarro, 2018, Podocytes are new cellular targets of haemoglobin-mediated renal damage, J Pathol, 244, 296, 10.1002/path.5011 Rubio-Navarro, 2019, Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury, Front Pharmacol, 10, 740, 10.3389/fphar.2019.00740 Guerrero-Hue, 2017, Targeting Nrf2 in Protection Against Renal Disease, Curr Med Chem, 24, 3583, 10.2174/0929867324666170511120814